Release Date: 30/08/12 13:51 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 7.2MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%